Category: NEWLY PUBLISHED
Billion Dollars Healthcare Startups (2018)
KEY POINTS A unicorn is a startup company with a current valuation of US$1 billion or more. Medgenera DATALABS has ...
Skin Cancers: The Sunny Challenge of Future (Potential Drugs and Treatments in Development)
KEY POINTS Ozone depletion, greenhouse gas-induced global warming, rising earth temperature is interacting to put a severe effect on human ...
Survey: 150 CEOs on the Most Valuable Job Skill for Mid-stage Healthcare Professionals
KEY POINTS A global survey of 150 healthcare industries CEOs plus 60 CSOs and COOs. Which skill contributed the MOST ...
Telemedicine a Blooming Area, Global Investments to Reach ~1 Billion in 2018: Medgenera Report
KEY POINTS About $725.9 million has been invested in telemedicine segment in 2017 by the global investors: Report Telemedicine is ...
Global Digital Health Investments Would Reach $10.3 B in 2018, Asia on the Rise: Medgenera’s Report
KEY POINTS Global digital health investment fundings (disclosed) is estimated to reach ~10.3 $ Billion in 2018. China and India ...
Top Companies Leading the Rare Disease Drug Discovery (2018)
KEY POINTS Here are the six companies playing on the front foot in the segment of rare diseases drug discovery. ...
7 New Ideas to Start a Healthcare Business in India (2018)
Seven new #healthcare #business ideas in India in 2018. Which one would you prefer to pursue?
Liquid Biopsy: The Golden Cancer Diagnostic Test (an Industrial Review)
KEY POINTS The liquid biopsy market is forecasted to grow at a CAGR of 20.6 percent to reach over $3 ...
World’s 10 Top-Selling Orphan Drugs 2018
KEY POINTS Here are the 10 top-selling orphan drugs in terms of their worldwide sales in the previous financial year. ...
Roche’s New Drug Shows Better Results than Renowned Tamiflu in Flu Patients
Roche’s investigational flu drug, Xofluza® (baloxavir marboxil) has reduced the risk of complications in patients with flu in a late-stage clinical study. It is the first single-dose, oral drug being developed for flu with a novel mechanism of action in about the last 20 years.